These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Clonal selection of HIV type 1 variants associated with resistance to foscarnet in vitro: confirmation by molecular evolutionary analysis. Nakano T; Morozumi H; Inuzuka S; Nagata M; Taguchi Y; Mizokami M; Okamoto T AIDS Res Hum Retroviruses; 1997 May; 13(7):563-73. PubMed ID: 9135874 [TBL] [Abstract][Full Text] [Related]
8. In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudine. Hostetler KY; Hammond JL; Kini GD; Hostetler SE; Beadle JR; Aldern KA; Chou TC; Richman DD; Mellors JW Antivir Chem Chemother; 2000 May; 11(3):213-9. PubMed ID: 10901292 [TBL] [Abstract][Full Text] [Related]
10. Alkoxy propane prodrugs of foscarnet: effect of alkyl chain length on in vitro antiviral activity in cells infected with HIV-1, HSV-1 and HCMV. Kini GD; Beadle JR; Xie H; Aldern KA; Richman DD; Hostetler KY Antiviral Res; 1997 Sep; 36(1):43-53. PubMed ID: 9330760 [TBL] [Abstract][Full Text] [Related]
11. Comparison of cellular accumulation, tissue distribution, and anti-HIV activity of free and liposomal 2',3'-dideoxycytidine. Makabi-Panzu B; Lessard C; Perron S; Désormeaux A; Tremblay M; Poulin L; Beauchamp D; Bergeron MG AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1463-70. PubMed ID: 7888201 [TBL] [Abstract][Full Text] [Related]
12. Intravitreal toxicology and therapeutic efficacy of the carboxymethyl ester of the 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA-O-Me), a novel lipid antiviral prodrug for intraocular drug delivery. Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Keefe KS; Beadle JR; Wiley CA; Freeman WR J Ocul Pharmacol Ther; 1999 Aug; 15(4):363-77. PubMed ID: 10463875 [TBL] [Abstract][Full Text] [Related]
13. Determination and pharmacokinetic profile of liposomal foscarnet in rabbit ocular tissues after intravitreal administration. Claro C; Ruiz R; Cordero E; Pastor MT; López-Cortés LF; Jiménez-Castellanos M; Lucero M Exp Eye Res; 2009 Mar; 88(3):528-34. PubMed ID: 19084004 [TBL] [Abstract][Full Text] [Related]
14. Treatment of herpes retinitis in an animal model with a sustained delivery antiviral drug, liposomal 1-O-octadecyl-SN-glycerol-3-phosphonoformate. Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Ozerdem U; Bergeron-Lynn G; Mach-Hofacre B; Mueller AJ; Severson GM; Freeman WR Retina; 1999; 19(4):325-31. PubMed ID: 10458299 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral activity of new carbonylphosphonate 2',3'-dideoxy-3'-thiacytidine conjugates. Charvet AS; Turin F; Faury P; Hantz O; Camplo M; Mourier N; Berthillon P; Graciet JC; Chermann JC; Trépo C Antiviral Res; 1994 Oct; 25(2):161-8. PubMed ID: 7847877 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of potential anti-AIDS agents thiofoscarnet and foscarnet in the cat. Straw JA; Loo TL; de Vera CC; Nelson PD; Tompkins WA; Bai SA J Acquir Immune Defic Syndr (1988); 1992; 5(9):936-42. PubMed ID: 1387417 [TBL] [Abstract][Full Text] [Related]
17. Increased efficacy of phosphonoformate and phosphonoacetate inhibition of herpes simplex virus type 2 replication by encapsulation in liposomes. Szoka FC; Chu CJ Antimicrob Agents Chemother; 1988 Jun; 32(6):858-64. PubMed ID: 2843083 [TBL] [Abstract][Full Text] [Related]
18. Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitro. Hostetler KY; Kini GD; Beadle JR; Aldern KA; Gardner MF; Border R; Kumar R; Barshak L; Sridhar CN; Wheeler CJ; Richman DD Antiviral Res; 1996 Jun; 31(1-2):59-67. PubMed ID: 8793009 [TBL] [Abstract][Full Text] [Related]
19. Encapsulation, pharmacokinetics and tissue distribution of interferon α-2b liposomes after intramuscular injection to rats. Li H; Yang L; Cheng G; Wei HY; Zeng Q Arch Pharm Res; 2011 Jun; 34(6):941-8. PubMed ID: 21725815 [TBL] [Abstract][Full Text] [Related]
20. Impaired fitness of foscarnet-resistant strains of human immunodeficiency virus type 1. Tachedjian G; Mellors JW; Bazmi H; Mills J AIDS Res Hum Retroviruses; 1998 Aug; 14(12):1059-64. PubMed ID: 9718121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]